Recombinant hirudin (Fosun Pharma)
重组水蛭素（上海复星生物医药）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant hirudin (Fosun Pharma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Lirui Biomedical Research Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A